Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PK150

Copy Product Info
😃Good
Catalog No. T7897Cas No. 2165324-62-7

PK150 shows oral bioavailability and antibacterial activity against several pathogenic strains at submicromolar concentrations.

PK150

PK150

Copy Product Info
😃Good
Purity: 99.54%
Catalog No. T7897Cas No. 2165324-62-7
PK150 shows oral bioavailability and antibacterial activity against several pathogenic strains at submicromolar concentrations.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$30In StockIn Stock
5 mg$48In StockIn Stock
10 mg$73In StockIn Stock
25 mg$146In StockIn Stock
50 mg$233In Stock-
100 mg$375In Stock-
200 mg$552InquiryInquiry
1 mL x 10 mM (in DMSO)$53In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.54%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

PK150 AI Summary
PK150 exhibits notable antibacterial activity against a range of bacterial strains including Staphylococcus aureus, vancomycin-resistant Enterococcus, and Mycobacterium tuberculosis. It effectively reduces microbial growth with Minimum Inhibitory Concentration (MIC) values of 0.18 ug/mL for Staphylococcus aureus, 1.0 ug/mL for vancomycin-resistant Enterococcus, and 0.93 ug/mL for Mycobacterium tuberculosis. Specifically against methicillin-resistant Staphylococcus aureus, it shows an MIC of 0.12 ug/mL and 300.0 nM measured after 24 hours. The compound also demonstrates efficacy against methicillin-sensitive Staphylococcus epidermidis and exhibits cytotoxicity against human HeLa and HepG2 cells..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
PK150 shows oral bioavailability and antibacterial activity against several pathogenic strains at submicromolar concentrations.
Targets&IC50
MRSA:0.3-1 µM (MIC), MSSA:0.3 µM (MIC), VISA:0.3 µM (MIC)
Chemical Properties
Molecular Weight394.68
FormulaC15H8ClF5N2O3
Cas No.2165324-62-7
SmilesFC(F)(F)c1cc(NC(=O)Nc2ccc3OC(F)(F)Oc3c2)ccc1Cl
Relative Density.1.63 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 250 mg/mL (633.42 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (12.67 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5337 mL12.6685 mL25.3370 mL126.6849 mL
5 mM0.5067 mL2.5337 mL5.0674 mL25.3370 mL
10 mM0.2534 mL1.2668 mL2.5337 mL12.6685 mL
20 mM0.1267 mL0.6334 mL1.2668 mL6.3342 mL
50 mM0.0507 mL0.2534 mL0.5067 mL2.5337 mL
100 mM0.0253 mL0.1267 mL0.2534 mL1.2668 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PK150 | purchase PK150 | PK150 cost | order PK150 | PK150 chemical structure | PK150 formula | PK150 molecular weight